Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
Business14 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General12 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General21 hours agoAustralia solved civilisation’s problems
-
Business19 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035